IR presentation at Korea Bio Investment Conference (2022.07.11) Date2022-07-22 View611 http://www.biospectator.com/view/news_view.php?varAtcId=16693 Prev Project MB201 selected as National New Drug Development Project (2022.05.10) Next [Notice] New stock issuance (2022.11.15) back to list
